https://www.openbell.ai/ 2026-10-02T16:58:01.938Z hourly 1.0 https://www.openbell.ai/support 2026-10-02T16:58:01.938Z monthly 0.7 https://www.openbell.ai/privacy 2026-10-02T16:58:01.938Z monthly 0.5 https://www.openbell.ai/terms 2026-10-02T16:58:01.938Z monthly 0.5 https://www.openbell.ai/feed.json 2026-10-02T16:58:01.938Z hourly 0.8 https://www.openbell.ai/news/XPO:1790960265926 2026-10-02T16:57:45.926Z daily 0.9 https://cdn.brandfetch.io/XPO/w/400/h/400?c=1idopYfmtR7ZKg8QMud XPO Could See More Upside as Shipments Outpace Peers, Says Bank of America XPO Inc. (NYSE: XPO) shares rose 4.76% to $188.28 after Bank of America Securities raised its price forecast to $230 from $228 and increased earnings estimates through 2028, citing market-share gains and improved margins. The analyst expects XPO's EPS to reach $1.59 for Q3 2026 and $5.48 for 2026, with revenue forecasts of $9.02 billion for 2026 and $9.91 billion for 2028. Additionally, XPO opened two new service centers, expanding its North American network to 300 locations. https://www.openbell.ai/news/PL:1790960232193 2026-10-02T16:57:12.193Z daily 0.9 https://cdn.brandfetch.io/PL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Planet Labs Stock Pops After 20 Satellite Launch Planet Labs PBC (NYSE: PL) shares surged 8.05% to $17.45 following the successful launch of 20 satellites aboard a SpaceX Falcon 9 rocket. This mission, which took place on Thursday, marked the company's fourth launch of the year and included a solar-powered prototype utilizing Google's custom AI chips. CEO Will Marshall highlighted the mission's goal of testing advanced machine learning hardware in orbit, as part of a long-term vision to establish data centers in space. https://www.openbell.ai/news/AAL:1790960020061 2026-10-02T16:53:40.061Z daily 0.9 https://cdn.brandfetch.io/AAL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Goldman Sachs Maintains Sell on American Airlines Group, Lowers Price Target to $11 Goldman Sachs analyst Catherine O'Brien has reiterated a 'Sell' rating on American Airlines Group (NASDAQ: AAL) and reduced the price target from $13 to $11. This adjustment reflects the firm's cautious outlook on the airline's performance. https://www.openbell.ai/news/NVDA:1790959959185 2026-10-02T16:52:39.185Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/02/3d-Render-Closeup-Of-Computer-Keyboard-W.jpg?width=250&height=187 Weak Jobs Report Lifts Nvidia, Nasdaq 100 to Record Highs: Stock Market Today U.S. stocks rose on Friday, with the Nasdaq 100 reaching a record high of 30,825.42, driven by a weaker-than-expected September jobs report that reduced expectations for Federal Reserve rate hikes. Nvidia Corp. hit a record share price of $237.88, contributing to a 1.1% gain in the Nasdaq. The nonfarm payrolls increased by only 29,000, significantly below the anticipated range of 84,000-90,000, while the unemployment rate rose to 4.2%. The S&P 500 and Dow Jones also saw gains of 0.6% and 0.3%, respectively. https://www.openbell.ai/news/BNY:1790959220826 2026-10-02T16:40:20.826Z daily 0.9 https://cdn.brandfetch.io/BNY/w/400/h/400?c=1idopYfmtR7ZKg8QMud JP Morgan Maintains Overweight on Bank of New York Mellon, Raises Price Target to $161 JP Morgan analyst Vivek Juneja has maintained an Overweight rating on Bank of New York Mellon (NYSE: BNY) and raised the price target from $159 to $161. https://www.openbell.ai/news/TFC:1790958904896 2026-10-02T16:35:04.896Z daily 0.9 https://cdn.brandfetch.io/TFC/w/400/h/400?c=1idopYfmtR7ZKg8QMud JP Morgan Maintains Underweight on Truist Financial, Lowers Price Target to $50.5 JP Morgan analyst Vivek Juneja has maintained an Underweight rating on Truist Financial (NYSE: TFC) and has reduced the price target from $54 to $50.5. https://www.openbell.ai/news/MAC:1790958370902 2026-10-02T16:26:10.902Z daily 0.9 https://cdn.brandfetch.io/MAC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Truist Securities Assumes Macerich at Buy, Maintains Price Target of $26 Truist Securities has initiated coverage on Macerich (NYSE: MAC) with a Buy rating. The firm has set a price target of $26 for the company's stock. https://www.openbell.ai/news/GS:1790958201851 2026-10-02T16:23:21.851Z daily 0.9 https://cdn.brandfetch.io/GS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Live On CNBC, Malcolm Ethridge Announces Bought More Goldman Sachs Group; Bought More Morgan Stanley openbell Financial News https://www.openbell.ai/news/REG:1790958201184 2026-10-02T16:23:21.184Z daily 0.9 https://cdn.brandfetch.io/REG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Truist Securities Assumes Regency Centers at Buy, Maintains Price Target of $84 Truist Securities has initiated coverage on Regency Centers (NASDAQ: REG) with a Buy rating. The firm has set a price target of $84 for the company's stock. https://www.openbell.ai/news/NKE:1790958146349 2026-10-02T16:22:26.349Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/02/Bangkok--Thailand---April-8--2018nike-Cl.jpg?width=250&height=187 Nike Is Still Searching for Its Turnaround As Wall Street Sees Another Tough Year Nike Inc. reported first-quarter revenue of $11.21 billion, missing analyst expectations of $11.33 billion, while adjusted earnings of 48 cents per share exceeded the 44-cent estimate. The company anticipates a high-single-digit percentage decline in revenue for fiscal 2027 and has lowered its adjusted earnings forecast to between $1.15 and $1.35 per share, below the $1.69 estimate. Following these results, analysts have cut their price targets, with Bank of America lowering its forecast to $24 from $30, and Guggenheim reducing its target to $50 from $60. Nike shares fell 5.49% to $33.22, marking a new 52-week low. https://www.openbell.ai/news/ON:1790957908245 2026-10-02T16:18:28.245Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/02/Konskie--Poland---January-22--2024-On-Se.jpg?width=250&height=187 ON Semiconductor Analyst's 5 Key Takeaways from Synaptics Acquistion ON Semiconductor Corp has revised its acquisition deal for Synaptics Inc, now valued at approximately $5.7 billion in an all-cash transaction. The company anticipates achieving $200 million in synergies within 18 months and expects the deal to add 50 cents per share to its non-GAAP earnings by 2028. The acquisition is projected to expand ON Semiconductor's total addressable market by $30 billion to $243 billion by 2030. Shares of ON Semiconductor rose 5.79% to $84.72 following the announcement. https://www.openbell.ai/news/META:1790957885371 2026-10-02T16:18:05.371Z daily 0.9 https://cdn.brandfetch.io/META/w/400/h/400?c=1idopYfmtR7ZKg8QMud Live On CNBC, Stephanie Link Announces Bought Meta Platforms openbell Financial News https://www.openbell.ai/news/ORCL:1790957762789 2026-10-02T16:16:02.789Z daily 0.9 https://cdn.brandfetch.io/ORCL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Live On CNBC, Jim Lebenthal Announces Bought More Oracle; Bought More Micron Technology openbell Financial News https://www.openbell.ai/news/QGEN:1790957693921 2026-10-02T16:14:53.921Z daily 0.9 https://cdn.brandfetch.io/QGEN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Watching Qiagen; Shares Move Higher; Traders Circulate M&A Blog Report Suggesting Talks With Strategic Buyer Have Advanced openbell Financial News https://www.openbell.ai/news/CURB:1790957533720 2026-10-02T16:12:13.720Z daily 0.9 https://cdn.brandfetch.io/CURB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Truist Securities Assumes Curbline Properties at Buy, Raises Price Target to $33 Truist Securities has initiated coverage on Curbline Properties (NYSE: CURB) with a Buy rating. Analyst Linda Tsai has also raised the price target for the stock to $33. https://www.openbell.ai/news/DVN:1790957362727 2026-10-02T16:09:22.727Z daily 0.9 https://cdn.brandfetch.io/DVN/w/400/h/400?c=1idopYfmtR7ZKg8QMud JP Morgan Maintains Overweight on Devon Energy, Raises Price Target to $65 JP Morgan analyst Arun Jayaram has maintained an Overweight rating on Devon Energy (NYSE: DVN) and has raised the price target from $60 to $65. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/NSTR:1790957166959 2026-10-02T16:06:06.959Z daily 0.9 https://cdn.brandfetch.io/NSTR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Reported Oct. 1: NorthStar Earth & Space Completes $300M Business Combination With Viking Acquisition NorthStar Earth & Space Inc. has completed a $300 million business combination with Viking Acquisition Corp. I, resulting in the formation of NorthStar Earth & Space Enterprises, Inc. The combined company's shares will begin trading on NYSE American under the ticker symbols 'NSTR' and 'NSTR.WS' starting October 2, 2026. Additionally, the transaction includes a $30 million common-stock PIPE financing to support the deployment of NorthStar's space-based sensor constellation. https://www.openbell.ai/news/NKE:1790957079056 2026-10-02T16:04:39.056Z daily 0.9 https://cdn.brandfetch.io/NKE/w/400/h/400?c=1idopYfmtR7ZKg8QMud JP Morgan Maintains Underweight on Nike, Lowers Price Target to $33 JP Morgan analyst Matthew Boss has maintained an Underweight rating on Nike (NYSE: NKE) and has lowered the price target from $40 to $33. This change reflects the analyst's cautious outlook on the company's performance. https://www.openbell.ai/news/RKLB:1790956984782 2026-10-02T16:03:04.782Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/02/Rocket-Lab.jpg?width=250&height=187 Why Is Rocket Lab Stock Surging on Friday? Rocket Lab (NASDAQ: RKLB) stock surged 6.29% to $74.89 on Friday, driven by a broader rally in space stocks and the announcement of a multi-year agreement to launch 20 Electron missions for Synspective, marking the largest commercial launch contract in Electron's history. This deal increases Synspective's total missions with Rocket Lab to 47, the highest for any customer, and adds to Rocket Lab's launch backlog, which now exceeds 100 missions. The missions are scheduled from 2028 to 2031, aiming to enhance Earth observation capabilities. https://www.openbell.ai/news/GOOGL:1790956805777 2026-10-02T16:00:05.777Z daily 0.9 https://cdn.brandfetch.io/GOOGL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Reported Oct. 1: Google Cloud Announces Availability Of Spanner Queues For Transactional Messaging In AI Agent Workloads Google Cloud has announced the general availability of Spanner Queues, designed for transactional messaging in AI agent workloads. This new feature aims to enhance the capabilities of Google Cloud's Spanner database, allowing for improved handling of AI-driven applications. The introduction of Spanner Queues is expected to strengthen Google Cloud's position in the competitive cloud services market. https://www.openbell.ai/news/SOC:1790956710463 2026-10-02T15:58:30.463Z daily 0.9 https://cdn.brandfetch.io/SOC/w/400/h/400?c=1idopYfmtR7ZKg8QMud JP Morgan Initiates Coverage On Sable Offshore with Overweight Rating, Announces Price Target of $10 JP Morgan has initiated coverage on Sable Offshore (NYSE: SOC) with an Overweight rating and set a price target of $10 for the stock. This marks a positive outlook for the company as it enters the market under JP Morgan's analysis. https://www.openbell.ai/news/META:1790956624982 2026-10-02T15:57:04.982Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/02/In-this-photo-illustration--the-Meta-Mus.jpg?width=250&height=187 5.6 Million Downloads in Weeks: Meta Muse Outpaces Sorad ChatGPT in Early Rollout Meta Platforms Inc. (NASDAQ: META) has achieved over 5.6 million downloads of its new app, Meta Muse, since its launch on September 8, surpassing early downloads of Sora and ChatGPT. Despite this initial success, BNP Paribas analyst Nick Jones cautions that long-term user engagement and monetization strategies remain unproven. Meta is currently focusing on adoption and engagement, with a price target of $885, indicating a potential 22% upside from its recent price of $731.62. https://www.openbell.ai/news/GHM:1790956580250 2026-10-02T15:56:20.250Z daily 0.9 https://cdn.brandfetch.io/GHM/w/400/h/400?c=1idopYfmtR7ZKg8QMud JP Morgan Initiates Coverage On Graham with Overweight Rating, Announces Price Target of $120 JP Morgan analyst Tomohiko Sano has initiated coverage on Graham (NYSE: GHM) with an Overweight rating. The firm has set a price target of $120 for the stock. https://www.openbell.ai/news/HESM:1790956395474 2026-10-02T15:53:15.474Z daily 0.9 https://cdn.brandfetch.io/HESM/w/400/h/400?c=1idopYfmtR7ZKg8QMud JP Morgan Downgrades Hess Midstream to Underweight, Maintains Price Target to $39 JP Morgan analyst Jeremy Tonet has downgraded Hess Midstream (NYSE: HESM) from Neutral to Underweight. The price target for the stock remains unchanged at $39. https://www.openbell.ai/news/PECO:1790956087509 2026-10-02T15:48:07.509Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/02/Two-Diverse-Crypto-Traders-Brokers-Stock.jpg?width=250&height=187 PECO Expands Northwestern Mutual Venture and Raises 2026 Acquisition Outlook Phillips Edison & Company (PECO) has expanded its joint venture with Northwestern Mutual, which will acquire 13 grocery-anchored shopping centers for approximately $377.5 million, with Northwestern Mutual owning 86% of the venture. PECO has raised its 2026 acquisition outlook to $600-$700 million from $500-$600 million and increased expected dispositions to $200-$250 million. The company reaffirmed its full-year earnings guidance, expecting diluted net income of 95-97 cents per share and Nareit FFO growth of 6.3% year-over-year. https://www.openbell.ai/news/CATX:1790956061087 2026-10-02T15:47:41.087Z daily 0.9 https://cdn.brandfetch.io/CATX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Perspective Therapeutics Reveals Acceptance Of [212Pb]VMT01 Data For Presentation At SITC 2026 Perspective Therapeutics, Inc. (NYSE: CATX) announced that data from its lapemelanotide zapixetar program, also known as [212Pb]VMT01, has been accepted for presentation at the Society for Immunotherapy of Cancer (SITC) 41st Annual Meeting, scheduled for November 4 to 8, 2026, in Phoenix, Arizona. Further details regarding the regular abstracts will be released by SITC on November 3, 2026. https://www.openbell.ai/news/HOOD:1790955982520 2026-10-02T15:46:22.520Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/02/The-Robinhood-Trade.jpg?width=250&height=187 How Robinhood's Meme Coin-Stock Pairings Became A 9-Figure Business Robinhood (NASDAQ: HOOD) has developed a platform allowing traders to pair real stocks with meme coins, creating a new category of on-chain speculation. Daily trading volume for these memecoin-stock-token pairs peaked at approximately $440 million in early September, with popular pairings including tokens linked to Nvidia, SpaceX, and Meta, reaching a combined market value of about $69 million. The SEC has granted temporary exemptions for trading tokenized US stocks on-chain, and Robinhood plans to expand its offerings with weekend US stock trading and leveraged perpetual futures on select cryptocurrencies. https://www.openbell.ai/news/AMZN:1790955971962 2026-10-02T15:46:11.962Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/02/Burry-Warns-AI-Bubble.jpg?width=250&height=187 AI Debt Is a ‘Brewing Crisis,’ Ed Zitron Warns as Amazon, CoreWeave Turn to Complex Financing Ed Zitron warns that the private credit funding the AI data-center sector is facing a 'brewing crisis' due to rising borrowing costs and delays in facility construction. Amazon is exploring a strategy to move $8 billion worth of Nvidia chips into a vehicle funded by outside investors, allowing them to lease the chips back to free up capital. CoreWeave Inc. reported $35.6 billion in debt as of June 30, heavily relying on private credit, while Goldman Sachs noted $88 billion in lower-rated AI-related borrowing this year. https://www.openbell.ai/news/EIX:1790955905399 2026-10-02T15:45:05.399Z daily 0.9 https://cdn.brandfetch.io/EIX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Jefferies Downgrades Edison International to Underperform, Lowers Price Target to $42 Jefferies analyst Paul Zimbardo has downgraded Edison International (NYSE:EIX) from Hold to Underperform. The price target for the stock has been reduced from $53 to $42. https://www.openbell.ai/news/BE:1790955558165 2026-10-02T15:39:18.165Z daily 0.9 https://cdn.brandfetch.io/BE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Bloom Energy shares are trading higher after Barclays raised its price target on the stock from $276 to $308. openbell Financial News https://www.openbell.ai/news/EXE:1790955549735 2026-10-02T15:39:09.735Z daily 0.9 https://cdn.brandfetch.io/EXE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Jefferies Maintains Buy on Expand Energy, Lowers Price Target to $136 Jefferies analyst Lloyd Byrne has maintained a Buy rating on Expand Energy (NASDAQ: EXE) but has lowered the price target from $143 to $136. This adjustment reflects a change in the analyst's outlook for the company's stock performance. https://www.openbell.ai/news/FRVO:1790955182856 2026-10-02T15:33:02.856Z daily 0.9 https://cdn.brandfetch.io/FRVO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Bernstein Reiterates Outperform on Fervo Energy, Maintains $47 Price Target Bernstein analyst Sunaina Ocalan has reiterated an 'Outperform' rating on Fervo Energy (NASDAQ: FRVO) and maintains a price target of $47 for the stock. No additional financial figures or strategic changes were mentioned in the article. https://www.openbell.ai/news/TSLA:1790954755232 2026-10-02T15:25:55.232Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/02/Kaunas--Lithuania-2022---April-14-Tesla-.jpg?width=250&height=187 Tesla Stock Gains As European Demand Boosts Q3 Deliveries Tesla, Inc. (NASDAQ: TSLA) reported a production increase to 464,391 vehicles in Q3 2026 from 447,450 in Q3 2025, while deliveries slightly declined to 486,532 vehicles but exceeded estimates. The stock rose nearly 5% to $371.79, driven by improved demand in Europe, which helped offset challenges in the U.S. and China. Analysts predict an EPS of 44 cents and revenue of $27.63 billion for the upcoming earnings report on October 22, 2026. https://www.openbell.ai/news/PFE:1790954337606 2026-10-02T15:18:57.606Z daily 0.9 https://cdn.brandfetch.io/PFE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Pfizer Announces Its Two Phase 3 Studies Of LITFULO Demonstrate TRANQUILLO 2 and TRANQUILLO, LITFULO Enhance Facial, Total Body Repigmentation Compared To Placebo; Co. Plans To File Data to Regulatory Authorities Globally, Include FDA And European Medicines Agency Pfizer Inc. announced positive results from two Phase 3 trials, TRANQUILLO 2 and TRANQUILLO, demonstrating that LITFULO (ritlecitinib) significantly enhances facial and total body repigmentation in patients with nonsegmental vitiligo compared to placebo. The studies showed improvements in disease severity and stabilization, supported by patient-reported outcomes. Pfizer plans to submit the trial data to regulatory authorities globally, including the FDA and EMA. https://www.openbell.ai/news/BX:1790954233340 2026-10-02T15:17:13.340Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/02/Konskie--Poland---November-21--2024-Blac.jpg?width=250&height=187 Blackstone Pours $1 Billion Into New Defense Tech Firm Blackstone Inc. has launched a new defense technology company named Falcata, formed through the acquisition of TSC and Applied Systems Engineering, with a commitment of over $1 billion in debt and equity to support its operations. Falcata will focus on missile defense technologies, enhancing capabilities in sensors, radar, and precision guidance. This investment is part of Blackstone's broader strategy, having invested approximately $20 billion in defense and aerospace over the past five years. Following the announcement, Blackstone's stock rose by 2.37% to $114.90. https://www.openbell.ai/news/AKR:1790954154236 2026-10-02T15:15:54.236Z daily 0.9 https://cdn.brandfetch.io/AKR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Truist Securities Assumes Acadia Realty Trust at Buy, Announces Price Target of $22 Truist Securities has initiated coverage of Acadia Realty Trust (NYSE: AKR) with a Buy rating. The firm has set a price target of $22 for the stock. https://www.openbell.ai/news/APLD:1790954046954 2026-10-02T15:14:06.954Z daily 0.9 https://cdn.brandfetch.io/APLD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Applied Digital shares are trading higher after the company announced it achieved Ready for Service for the second phase of Building 2 at its Polaris Forge 1 campus. openbell Financial News https://www.openbell.ai/news/OVV:1790953752345 2026-10-02T15:09:12.345Z daily 0.9 https://cdn.brandfetch.io/OVV/w/400/h/400?c=1idopYfmtR7ZKg8QMud Scotiabank Maintains Sector Outperform on Ovintiv, Raises Price Target to $75 Scotiabank analyst Kevin Fisk has maintained a Sector Outperform rating on Ovintiv (NYSE: OVV) and increased the price target from $70 to $75. https://www.openbell.ai/news/LITE:1790953674658 2026-10-02T15:07:54.658Z daily 0.9 https://cdn.brandfetch.io/LITE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Watching Lumentum; Hearing Investor Business Daily SwingTrader Buys Stock openbell Financial News https://www.openbell.ai/news/LEN:1790953588786 2026-10-02T15:06:28.786Z daily 0.9 https://cdn.brandfetch.io/LEN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Watching Lennar; Hunterbrook Media Issues Report Titled, “Lennar’s Big New Customer Is Its Own Spinoff, Millrose”; States Hunterbrook Capital Is Short $LEN; Short $MRP Hunterbrook Media has released a report titled 'Lennar’s Big New Customer Is Its Own Spinoff, Millrose,' indicating that Hunterbrook Capital is short on Lennar Corporation (ticker: LEN) and Millrose (ticker: MRP). The report suggests a strategic relationship between Lennar and its spinoff, Millrose, which may impact market perceptions. Further details regarding financial implications or stock price movements were not provided in the article. https://www.openbell.ai/news/BNL:1790953510645 2026-10-02T15:05:10.645Z daily 0.9 https://cdn.brandfetch.io/BNL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Truist Securities Upgrades Broadstone Net Lease to Buy, Lowers Price Target to $21 Truist Securities has upgraded Broadstone Net Lease (NYSE: BNL) from a Hold to a Buy rating. Alongside this upgrade, analyst Linda Tsai has lowered the price target for the stock from $22 to $21. https://www.openbell.ai/news/BMRN:1790953309986 2026-10-02T15:01:49.986Z daily 0.9 https://cdn.brandfetch.io/BMRN/w/400/h/400?c=1idopYfmtR7ZKg8QMud BioMarin Pharmaceutical Presents New Efficacy Data On POMBILITI + OPFOLDA In Pompe Disease At 31st Annual Congress Of World Muscle Society; No New Safety Signals Identified BioMarin Pharmaceutical Inc. presented new efficacy data on its treatments POMBILITI (cipaglucosidase alfa-atga) and OPFOLDA (miglustat) for late-onset Pompe disease at the 31st Annual Congress of the World Muscle Society in Hiroshima, Japan. The company reported no new safety signals associated with the treatments. https://www.openbell.ai/news/NVDA:1790953222970 2026-10-02T15:00:22.970Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/02/CoreWeave.jpg?width=250&height=187 CoreWeave Unleashes Nvidia's Vera Rubin, Analyst Sees Room to Run CoreWeave Inc. (NASDAQ: CRWV) has launched the Nvidia Vera Rubin NVL72 AI supercomputer platform, with Cognition as its first customer reporting up to 4.8× higher token throughput compared to Nvidia's previous model. Analyst Brett Knoblauch maintained an Overweight rating with a price target of $176, citing an attractive entry point for investors. CoreWeave has also introduced Forge, a new software platform, and expanded its partner network, while indicating a strong demand for its services with a target of 8 GW capacity by 2030. Shares of CoreWeave rose by 3.43% to $91.61 at the time of publication. https://www.openbell.ai/news/PLTR:1790953196343 2026-10-02T14:59:56.343Z daily 0.9 https://cdn.brandfetch.io/PLTR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Watching Palantir Technologies; Hearing Investor Business Daily SwingTrader Buys Stock openbell Financial News https://www.openbell.ai/news/NEE:1790953194851 2026-10-02T14:59:54.851Z daily 0.9 https://cdn.brandfetch.io/NEE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Seaport Global Maintains Sell on NextEra Energy, Raises Price Target to $56 Seaport Global analyst Angie Storozynski has maintained a 'Sell' rating on NextEra Energy (NYSE: NEE) while raising the price target from $55 to $56. https://www.openbell.ai/news/MGY:1790952960353 2026-10-02T14:56:00.353Z daily 0.9 https://cdn.brandfetch.io/MGY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Truist Securities Maintains Buy on Magnolia Oil & Gas, Raises Price Target to $35 Truist Securities analyst Gabe Daoud has maintained a Buy rating on Magnolia Oil & Gas (NYSE: MGY) and raised the price target from $34 to $35. This adjustment reflects a positive outlook for the company's stock performance. https://www.openbell.ai/news/IVA:1790952887270 2026-10-02T14:54:47.270Z daily 0.9 https://cdn.brandfetch.io/IVA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Truist Securities Maintains Buy on Inventiva, Raises Price Target to $18 Truist Securities analyst Srikripa Devarakonda has maintained a Buy rating on Inventiva (NASDAQ: IVA) and raised the price target from $13 to $18. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/QQQ:1790952886265 2026-10-02T14:54:46.265Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/02/Federal-Reserve-Chair-Kevin-Warsh-Delive.jpg?width=250&height=187 Fed Hike Odds Collapse to 16% on Prediction Markets After Soft Jobs Report The odds of a Federal Reserve interest rate hike in October fell to 16% following a disappointing jobs report, which showed only 29,000 jobs added in September, significantly below the expected 90,000. The unemployment rate increased to 4.2%, and wage growth slowed. In contrast, traders still anticipate a 68% chance of a rate hike in December. Following the news, stocks rallied, with the SPDR S&P 500 ETF Trust rising about 1% and the Invesco QQQ Trust gaining 1.5%. https://www.openbell.ai/news/MBX:1790952816538 2026-10-02T14:53:36.538Z daily 0.9 https://cdn.brandfetch.io/MBX/w/400/h/400?c=1idopYfmtR7ZKg8QMud MBX Biosciences shares are trading higher after Guggenheim maintained a Buy rating on the stock and raised its price target from $88 to $150. openbell Financial News https://www.openbell.ai/news/AKTS:1790952629116 2026-10-02T14:50:29.116Z daily 0.9 https://cdn.brandfetch.io/AKTS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Wedbush Reiterates Outperform on Aktis Oncology, Maintains $35 Price Target Wedbush analyst David Nierengarten has reiterated an 'Outperform' rating on Aktis Oncology (NASDAQ: AKTS) and has maintained a price target of $35 for the stock.